Erratum to: Breast Cancer Res Treat DOI 10.1007/s10549-014-3042-3
In the original publication, an acknowledgement has been inadvertently omitted. The acknowledgement is given below:
Acknowledgments
Vakaramoko Diaby and Georges Adunlin have equal contribution in terms of authorship.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s10549-014-3042-3.
Rights and permissions
About this article
Cite this article
Diaby, V., Adunlin, G., Zeichner, S.B. et al. Erratum to: Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer. Breast Cancer Res Treat 147, 443 (2014). https://doi.org/10.1007/s10549-014-3107-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-014-3107-3